M. J. Mcgeachy, D. J. Cua, and S. L. Gaffen, The IL-17 Family of Cytokines in Health and Disease, Immunity, vol.50, pp.892-906, 2019.

J. K. Kolls and A. Lindén, Interleukin-17 Family Members and Inflammation, Immunity, vol.21, pp.467-476, 2004.

R. Pappu, V. Ramirez-carrozzi, and A. Sambandam, The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases, Immunology, vol.134, pp.8-16, 2011.

A. Beringer, M. Noack, and P. Miossec, IL-17 in Chronic Inflammation: From Discovery to

. Targeting, Trends Mol Med, vol.22, pp.230-241, 2016.

S. Cochaud, J. Giustiniani, C. Thomas, E. Laprevotte, C. Garbar et al.,

C. Mascaux, G. Alberici, and N. Bonnefoy, IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2, Sci Rep, vol.3, p.3456, 2013.

A. S. Chung, X. Wu, G. Zhuang, H. Ngu, I. Kasman et al.,

P. Yg and . Fv, An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy, Nat Med, vol.19, pp.1114-1123, 2013.

H. Li, J. Chen, A. Huang, J. Stinson, S. Heldens et al.,

, Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family, Proc Natl Acad Sci, vol.97, pp.773-778, 2000.

Y. Shi, S. J. Ullrich, J. Zhang, K. Connolly, K. J. Grzegorzewski et al., A Novel Cytokine Receptor-Ligand Pair: IDENTIFICATION, MOLECULAR CHARACTERIZATION, AND IN VIVO IMMUNOMODULATORY ACTIVITY, J Biol Chem, vol.275, pp.19167-19176, 2000.

Q. Bie, B. Zhang, C. Sun, J. X. Barnie, P. A. Qi et al.,

, IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells, Oncotarget, vol.8, 2017.

E. Laprevotte, S. Cochaud, S. Du-manoir, M. Lapierre, C. Dejou et al.,

J. Frewer, K. A. Sanders, A. J. Jiang, and W. G. , The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway, Oncotarget, vol.8, pp.113360-113372, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02382938

H. Wu, W. W. Hwang-verslues, W. Lee, C. Huang, P. Wei et al.,

Y. , L. Jeng, Y. Tien, and Y. , Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines, J Exp Med, vol.212, pp.333-349, 2015.

Y. Yang, Y. Lee, S. Lo, Y. Chung, Y. Hsieh et al., A positive feedback loop of IL-17B-IL-17RB activates ERK/?-catenin to promote lung cancer metastasis

, Cancer Lett, vol.422, pp.44-55, 2018.

Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae, Functional specialization of interleukin-17 family members, Immunity, vol.34, pp.149-162, 2011.

V. Kouri, J. Olkkonen, M. Ainola, T. Li, L. Björkman et al.,

, Neutrophils produce interleukin-17B in rheumatoid synovial tissue, Rheumatol Oxf Engl, vol.53, pp.39-47, 2014.

T. Kokubu, D. R. Haudenschild, T. A. Moseley, L. Rose, and A. H. Reddi, Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing, J Histochem Cytochem Off J Histochem Soc, vol.56, pp.89-95, 2008.

E. E. Moore, S. Presnell, U. Garrigues, A. Guilbot, E. Leguern et al., Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease, Neuromuscul Disord NMD, vol.12, pp.141-150, 2002.

E. Ferretti, M. Ponzoni, C. Doglioni, and V. Pistoia, IL-17 superfamily cytokines modulate normal germinal center B cell migration, J Leukoc Biol, vol.100, pp.913-918, 2016.

M. Novatchkova, A. Leibbrandt, J. Werzowa, A. Neubüser, and F. Eisenhaber, The STIRdomain superfamily in signal transduction, development and immunity, Trends Biochem Sci, vol.28, pp.226-229, 2003.

J. Lee, W. Ho, M. Maruoka, R. T. Corpuz, D. T. Baldwin et al.,

. Dg, R. L. Vandlen, and W. I. Wood, IL-17E, a Novel Proinflammatory Ligand for the, p.17

, Receptor Homolog IL-17Rh1, J Biol Chem, vol.276, pp.1660-1664, 2001.

V. Ramirez-carrozzi, N. Ota, A. Sambandam, K. Wong, J. Hackney et al.,

W. Ouyang and R. Pappu, Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes, J Immunol, vol.202, pp.1935-1941, 2019.

S. L. Gaffen, Structure and signalling in the IL-17 receptor family, Nat Rev Immunol, vol.9, pp.556-567, 2009.

Y. Wang, P. Angkasekwinai, N. Lu, K. S. Voo, K. Arima et al.,

C. J. Corrigan, C. Dong, and B. Homey, IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells, J Exp Med, vol.204, pp.1837-1847, 2007.

Y. Maezawa, H. Nakajima, K. Suzuki, T. Tamachi, K. Ikeda et al.,

, Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling, J Immunol Baltim Md, vol.1950, pp.1013-1018, 2006.

C. K. Wong, P. Cheung, W. K. Ip, and C. Lam, Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB, Am J Respir Cell Mol Biol, vol.33, pp.186-194, 2005.

Y. Yamaguchi, K. Fujio, H. Shoda, A. Okamoto, N. H. Tsuno et al.,

I. Il-17b, Are Associated with TNF-? Production and Contribute to the Exacerbation of Inflammatory Arthritis, J Immunol, vol.179, pp.7128-7136, 2007.

J. M. Reynolds, Y. Lee, Y. Shi, X. Wang, P. Angkasekwinai et al.,

S. , C. Sh, H. Watarai, C. Dong, S. Furuta et al., Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation, IL-25 Causes Apoptosis of IL-25R-Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells, vol.42, pp.692-703, 2015.

, Sci Transl Med, vol.3, pp.78-109, 2011.

C. Huang, Y. Jeng, Y. Chen, C. Wu, H. Chang et al.,

K. Chang and J. Shew, Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-?B-mediated antiapoptotic pathway, Oncogene, vol.33, pp.2968-2977, 2014.

S. Huang, P. Wei, W. W. Hwang-verslues, W. Kuo, Y. Jeng et al.,

K. and L. E. , TGF-?1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB, EMBO Mol Med, vol.9, pp.1660-1680, 2017.

Q. Bie, P. Zhang, Z. Su, D. Zheng, X. Ying et al.,

, Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric Cancer, J Immunol Res, vol.2014, pp.1-10, 2014.

Q. Bie, C. Sun, A. Gong, C. Li, Z. Su et al., Nontumor tissue derived interleukin-17B activates IL-17RB/AKT/?-catenin pathway to enhance the stemness of gastric cancer, Sci Rep, vol.6, p.25447, 2016.

J. Cai, W. Zhang, P. Yang, Y. Wang, M. Li et al.,

, Identification of a 6-Cytokine Prognostic Signature in Patients with Primary Glioblastoma Harboring M2 Microglia/Macrophage Phenotype Relevance, PLOS ONE, vol.10, p.126022, 2015.

S. Leivonen, M. Pollari, O. Brück, T. Pellinen, M. Autio et al.,

S. Mannisto, P. Kellokumpu-lehtinen, O. Kallioniemi, and S. Mustjoki, T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma

, Haematologica, vol.104, pp.338-346, 2019.

A. Al-samadi, S. Moossavi, A. Salem, M. Sotoudeh, S. M. Tuovinen et al.,

T. Bishehsari and F. , Distinctive expression pattern of interleukin-17 cytokine family members in colorectal cancer, Tumor Biol, vol.37, pp.1609-1615, 2016.

N. Eiro, J. Fernandez-gomez, R. Sacristán, and B. Fernandez-garcia,

J. Suarez, A. Quintas, S. Escaf, and F. J. Vizoso, Stromal factors involved in human prostate cancer development, progression and castration resistance, J Cancer Res Clin Oncol, vol.143, pp.351-359, 2017.

A. Lavorgna, M. Matsuoka, and E. W. Harhaj, A Critical Role for IL-17RB Signaling in HTLV-1 Tax-Induced NF-?B Activation and T-Cell Transformation, PLoS Pathog, vol.10, 2014.

L. Ren, Y. Xu, C. Liu, S. Wang, and G. Qin, IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression, Mol Immunol, vol.90, pp.126-135, 2017.

H. Guo, L. Niu, W. Qiang, C. J. Wang, J. Yang et al.,

, Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance, FASEB J, vol.33, pp.9565-9576, 2019.